Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study explores whether DESI-MS can be used to identify cancerous vs. noncancerous tissue during brain tumor surgery.
Full description
PRIMARY OBJECTIVES:
I. To explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative diagnostic tool to:
Ia. Identify cancerous versus noncancerous tissue and estimate the percentage of tumor infiltration in tissue biopsies, by monitoring depletion of N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; Ib. Identify the presence of IDH mutations by monitoring the 2-hydroxyglutarate (2HG) and therefore differentiate between IDH-mutant and wild-type gliomas.
OUTLINE: This is an observational study.
Patients undergo tissue sample collection and DESI-MS during standard of care surgery and have their medical records reviewed on study. Patients also undergo MRI per standard of care on study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
285 participants in 1 patient group
Loading...
Central trial contact
Clinical Trials Referral Office; Alleshba Basil
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal